Arexvy, world's first RSV vaccine has been approved by the US FDA for use in people above 60 years of age. The vaccine has been manufactured by GSK and is said to reduce risk of developing severe disease by 92.1%.World's first RSV vaccine gets approval
GeneralArexvy, world's first RSV vaccine has been approved by the US FDA for use in people above 60 years of age. The vaccine has been manufactured by GSK and is said to reduce risk of developing severe disease by 92.1%.
Comments